Nutraferon I TEN 100MG INJECTION 5ML Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
ELEMENTAL IRON-20MG
Uses:
management and Treatment of Iron deficiency and anaemia
Medicinal Benefits:
Nutraferon I TEN 100MG INJECTION 5ML is used to treat iron deficiency and anaemia (deficiency of red blood cells and haemoglobin). It contains 'Elemental Iron,' an essential body mineral required by the red blood cells to carry oxygen to other body cells and tissues. By combining with a protein in the blood called haemoglobin, iron helps carry adequate oxygen to various body parts. It is generally used in patients for whom oral forms of iron are not suitable or ineffective.
Nutraferon I TEN 100MG INJECTION 5ML is used to treat iron deficiency and anaemia (deficiency of iron and haemoglobin).
Nutraferon I TEN 100MG INJECTION 5ML contains Elemental Iron. It works by boosting the production of red blood cells (RBC) in the body, thus treating iron deficiency and its associated anaemia.
Nutraferon I TEN 100MG INJECTION 5ML should be used with caution and only under doctor's supervision if you have heart, liver or kidney diseases, low blood pressure, iron overload disorders like hemochromatosis, lupus (immune disorder), rheumatoid arthritis, asthma, and eczema.
Nutraferon I TEN 100MG INJECTION 5ML can be given to patients above 65 years of age under the supervision of a doctor. However, due to the reduced liver, kidney and heart function in older people who also use other medicines, Nutraferon I TEN 100MG INJECTION 5ML should be cautiously administered.
Nutraferon I TEN 100MG INJECTION 5ML may cause constipation as one of its side effects. Eating fibre-rich foods like vegetables, fresh fruits, and cereals and drinking plenty of water can help relieve symptoms.
Antacids may interfere with the absorption of iron. Hence it is advised to take Nutraferon I TEN 100MG INJECTION 5ML two hours before or four hours after taking antacids.
Nutraferon I TEN 100MG INJECTION 5ML may cause side effects such as nausea, vomiting, taste changes, constipation, headache, back pain or cough. If these side effects persist or worsen, please consult your doctor.
Iron-deficiency or anemia can be defined as a lack of adequate amounts of healthy red blood cells, which carry oxygen to the body's tissues. Lack of red blood cells may cause pale skin, weakness, fatigue (overtiredness), brittle nails, etc.
The food sources of iron include white beans, spinach, lentils, peas and kidney beans, lean meat, chicken, seafood, nuts and some dried fruits, such as raisins. Also, iron-protected breakfast cereals and bread.
There is limited information on the safety of Nutraferon I TEN 100MG INJECTION 5ML in pregnancy. Therefore, please let your doctor know if you are pregnant or planning to conceive before starting Nutraferon I TEN 100MG INJECTION 5ML.
Anemia is a blood disorder which occurs when the number of red blood cells (RBCs) that carry oxygen is lower than usual. As a result, your tissues and organs don’t get adequate oxygen. Megaloblastic anemia is a form of anemia characterized by very large red blood cells and a decrease in their number. Generally, megaloblastic anemia is due to vitamin B12 or folic acid deficiency.
Nutraferon I TEN 100MG INJECTION 5ML starts working within 5 minutes of giving it. However, the duration may vary depending on the severity, dose, type of cancer and other cancer medications used along with Nutraferon I TEN 100MG INJECTION 5ML.
Your doctor will advise blood tests to check your levels of serum methotrexate concentration (in case of methotrexate chemotherapy or overdose) to determine the best dose and duration of treatment with Nutraferon I TEN 100MG INJECTION 5ML. A complete blood count may also be recommended to monitor the number of red blood cells (in case of megaloblastic anemia). In order to prevent hypercalcemia (excess calcium), your calcium levels will also be monitored since Nutraferon I TEN 100MG INJECTION 5ML contains calcium.
Adult’s urine output should be maintained above 2,500 mL/24hr by increasing oral or intravenous fluids 12 hours before and for 36 hours after the end of methotrexate infusion. Monitor alkalinization of urine (this enhances drug excretion) so that the urinary pH is greater than 7.0 before methotrexate infusion. Drinks, foods and drugs that may increase urinary acidity should be avoided during the therapy. Finally, blood methotrexate concentration should be measured at least 24, 48, and 72 hours after starting the methotrexate infusion.